Yu, Gechang
Tam, Henry C. H.
Huang, Chuiguo
Shi, Mai
Lim, Cadmon K. P.
Chan, Juliana C. N.
Ma, Ronald C. W.
Funding for this research was provided by:
Chinese University of Hong Kong Provost’s Scheme for PhD scholarship
Innovation and Technology Fund Midstream Research Programme for Universities (MRP/054/20X, MRP/054/20X, MRP/054/20X)
Chinese University of Hong Kong Research Committee Postdoctoral Fellowship Scheme
Innovation and Technology Commission Research Talent Hub
Research Grants Council of the Hong Kong Special Administrative Region (CU R4012-18, CU R4012-18, CU R4012-18)
Hong Kong Government Health and Medical Research Fund (CFS-CUHK2, CFS-CUHK2)
Hong Kong Genome Institute
the University Grants Committee Research Grants Matching Scheme
AstraZeneca (Investigator-initiated study)
Article History
Accepted: 4 January 2024
First Online: 31 January 2024
Declarations
:
: Not applicable for this review article.
: JCNC, CKPL, RCWM are co-founders of GemVCare, a technology start-up initiated with support from the Hong Kong Government Innovation and Technology Commission and its Technology Start-up Support Scheme for Universities (TSSSU).
: All reported studies/experiments with human or animal subjects performed by the authors were performed in accordance with all applicable ethical standards including the Helsinki declaration and its amendments, institutional/national research committee standards, and international/national/institutional guidelines.